Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077844
Status:
COMPLETED
Last Update Posted:
2011-01-11
First Post:
2004-02-12
Brief Title:
Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention PCI Patients an International Randomized Evaluation STEEPLE
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
An International Phase 2-3 Stratified Randomized Open-label Parallel-group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-emergent Percutaneous Coronary Intervention
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of intravenous enoxaparin versus intravenous unfractionated heparin UFH in patients undergoing non-emergent PCI as assessed by measuring the incidence of non-coronary artery bypass graft CABG major and minor bleeding
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2004-003743-44 | None | None | None |